What's Happening?
A recent study published in Nature Metabolism has found that glucosamine supplements, commonly used for joint pain relief, may accelerate memory loss in individuals with Alzheimer's disease. The research, conducted by a team at the University of Florida,
analyzed anonymized medical records of 24,000 patients with dementia and 41,000 with mild cognitive impairment. The findings revealed that Alzheimer's patients taking glucosamine were 25% more likely to die within five years compared to those who did not take the supplement. Additionally, those with mild cognitive impairment who consumed glucosamine were 25% more likely to progress to full Alzheimer's. The study also included experiments on mice engineered to have Alzheimer's-like symptoms, which showed that glucosamine worsened memory loss, while blocking the enzyme that produces glucosamine improved symptoms.
Why It's Important?
The study raises significant concerns about the safety of glucosamine supplements for individuals with cognitive decline. Given that glucosamine is widely available over the counter and used by millions for joint health, these findings could impact public health recommendations and consumer behavior. The research suggests that while glucosamine may be safe for healthy individuals, it poses risks for those with existing cognitive issues. This could lead to increased scrutiny and potential regulatory changes regarding the labeling and sale of glucosamine supplements, particularly for vulnerable populations such as the elderly or those with early signs of dementia.
What's Next?
Further research is needed to confirm these findings and explore the mechanisms by which glucosamine affects cognitive decline. The study's authors suggest that a clinical trial involving patients who discontinue glucosamine could provide more definitive evidence. Additionally, the team plans to investigate whether other supplements metabolized similarly to glucosamine pose similar risks. These efforts could inform future guidelines and recommendations for supplement use among individuals at risk of or experiencing cognitive decline.
